[Congressional Record Volume 164, Number 97 (Tuesday, June 12, 2018)]
[Senate]
[Pages S3775-S3776]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 2796. Mr. KENNEDY submitted an amendment intended to be proposed 
to amendment SA 2282 proposed by Mr. Inhofe (for himself and Mr. 
McCain) to the bill H.R. 5515, to authorize appropriations for fiscal 
year 2019 for military activities of the Department of Defense, for 
military construction, and for defense activities of the Department of 
Energy, to prescribe military personnel strengths for such fiscal year, 
and for other purposes; which was ordered to lie on the table; as 
follows:

       At the end of subtitle I of title VIII, add the following:

     SEC. 896. COMMERCIALIZATION ASSISTANCE PILOT PROGRAM.

       Section 9 of the Small Business Act (15 U.S.C. 638) is 
     amended by adding at the end the following:
       ``(tt) Commercialization Assistance Pilot Programs.--
       ``(1) Pilot programs implemented.--
       ``(A) In general.--Except as provided in subparagraph (B), 
     not later than 1 year after the date of enactment of this 
     subsection, a covered agency shall implement a 
     commercialization assistance pilot program under which an 
     eligible entity may receive a subsequent Phase II SBIR award.
       ``(B) Exception.--If the Administrator determines that a 
     covered agency has a program that is sufficiently similar to 
     the commercialization assistance pilot program established 
     under this subsection, the covered agency shall not be 
     required to implement a commercialization assistance pilot 
     program under this subsection.
       ``(2) Percent of agency funds.--The head of each covered 
     agency may allocate not more than 5 percent of the funds 
     allocated to the SBIR program of the covered agency for the 
     purpose of making a subsequent Phase II SBIR award under the 
     commercialization assistance pilot program.
       ``(3) Termination.--A commercialization assistance pilot 
     program established under this subsection shall terminate on 
     September 30, 2022.
       ``(4) Application.--To be selected to receive a subsequent 
     Phase II SBIR award under a commercialization assistance 
     pilot program, an eligible entity shall submit to the covered 
     agency implementing the pilot program an application at such 
     time, in such manner, and containing such information as the 
     covered agency may require, including--
       ``(A) an updated Phase II commercialization plan; and
       ``(B) the source and amount of the matching funding 
     required under paragraph (5).
       ``(5) Matching funding.--
       ``(A) In general.--The Administrator shall require, as a 
     condition of any subsequent Phase II SBIR award made to an 
     eligible entity under this subsection, that a matching amount 
     (excluding any fees collected by the eligible entity 
     receiving the award) equal to the amount of the award be 
     provided from an eligible third party investor.
       ``(B) Ineligible sources.--An eligible entity may not use 
     funding from ineligible sources to meet the matching 
     requirement of subparagraph (A).
       ``(C) Exception.--The Administrator shall not require, as a 
     condition of any subsequent Phase II SBIR award made to an 
     eligible entity under this subsection, a matching amount if 
     the eligible entity is located in an underperforming State.
       ``(6) Award.--A subsequent Phase II SBIR award made to an 
     eligible entity under this subsection--
       ``(A) may not exceed the limitation described under 
     subsection (aa)(1); and
       ``(B) shall be disbursed during Phase II.
       ``(7) Use of funds.--The funds awarded to an eligible 
     entity under this subsection may only be used for research 
     and development activities that build on Phase II program of 
     the eligible entity's and ensure the research funded under 
     that Phase II is rapidly progressing towards 
     commercialization.
       ``(8) Selection.--In selecting eligible entities to 
     participate in a commercialization assistance pilot program 
     under this subsection, the head of a covered agency shall 
     consider--
       ``(A) the extent to which the award could aid the eligible 
     entity in commercializing the research funded under the Phase 
     II program of the eligible entity;
       ``(B) whether the updated Phase II commercialization plan 
     submitted under paragraph (4) provides a sound approach for 
     establishing technical feasibility that could lead to 
     commercialization of the research;
       ``(C) whether the proposed activities to be conducted under 
     the updated Phase II commercialization plan further improve 
     the likelihood that the research will provide societal 
     benefits;
       ``(D) whether the small business concern has progressed 
     satisfactorily in Phase II to justify receipt of a subsequent 
     Phase II SBIR award;
       ``(E) the expectations of the eligible third party investor 
     that provides matching funding under paragraph (5); and
       ``(F) the likelihood that the proposed activities to be 
     conducted under the updated Phase II commercialization plan 
     using matching funding provided by the eligible third party 
     investor will lead to commercial and societal benefit.
       ``(9) Evaluation report.--Not later than 3 years after the 
     date of enactment of this subsection, the Comptroller General 
     of the United States shall submit to the Committee on Small 
     Business and Entrepreneurship of the Senate and the Committee 
     on Science, Space, and Technology and the Committee on Small 
     Business of the House of Representatives a report including--
       ``(A) a summary of the activities of commercialization 
     assistance pilot programs carried out under this subsection;
       ``(B) a detailed compilation of results achieved by those 
     commercialization assistance pilot programs, including the 
     number of eligible entities that received awards under those 
     programs;
       ``(C) the rate at which each eligible entity that received 
     a subsequent Phase II SBIR award under this subsection 
     commercialized research of the recipient;
       ``(D) the growth in employment and revenue of eligible 
     entities that is attributable to participation in a 
     commercialization assistance pilot program;
       ``(E) a comparison of commercialization success of eligible 
     entities participating in a commercialization assistance 
     pilot program with recipients of an additional Phase II SBIR 
     award under subsection (ff);
       ``(F) demographic information, such as ethnicity and 
     geographic location, of eligible entities participating in a 
     commercialization assistance pilot program;
       ``(G) an accounting of the funds used at each covered 
     agency that implements a commercialization assistance pilot 
     program under this subsection;
       ``(H) the amount of matching funding provided by eligible 
     third party investors, set forth separately by source of 
     funding;
       ``(I) an analysis of the effectiveness of the 
     commercialization assistance pilot program implemented by 
     each covered agency; and
       ``(J) recommendations for improvements to the 
     commercialization assistance pilot program.
       ``(10) Definitions.--For purposes of this subsection:
       ``(A) Covered agency.--The term `covered agency' means a 
     Federal agency required to have an SBIR program.
       ``(B) Eligible entity.--The term `eligible entity' means a 
     small business concern that has received a Phase II award 
     under an SBIR program and an additional Phase II SBIR award 
     under subsection (ff) from the covered agency to which the 
     small business concern is applying for a subsequent Phase II 
     SBIR award.
       ``(C) Eligible third party investor.--The term `eligible 
     third party investor' means a small business concern other 
     than an eligible entity, a venture capital firm, an 
     individual investor, a non-SBIR Federal, State or local 
     government, or any combination thereof.
       ``(D) Ineligible sources.--The term `ineligible sources' 
     means the following:
       ``(i) The internal research and development funds of the 
     eligible entity.
       ``(ii) Funding in forms other than cash, such as in-kind or 
     other intangible assets.
       ``(iii) Funding from the owners of the eligible entity, or 
     the family members or affiliates of those owners.
       ``(iv) Funding attained through loans or other forms of 
     debt obligations.
       ``(E) Subsequent phase ii sbir award.--The term `subsequent 
     Phase II SBIR award' means an award granted to an eligible 
     entity under this subsection to carry out further 
     commercialization activities for research conducted pursuant 
     to an SBIR program.
       ``(F) Underperforming state.--The term `underperforming 
     State' means any State

[[Page S3776]]

     participating in the SBIR program that is in the bottom 50 
     percent of all States historically receiving SBIR program 
     funding.''.
                                 ______